A case report of mitral valve replacement in a patient with lupus antibody syndrome

Perfusion

Volumn 18, Issue 6, 2003, Pages 373-376

  Brownstein, Louis ^a   Bartholomew, Terry P ^a   Silver, David G ^a   Berry, Charles M ^a  

^a Cheyenne Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; APROTININ; ATENOLOL; HEPARIN; LUPUS ANTICOAGULANT; METOPROLOL TARTRATE; POTASSIUM; PROTAMINE; QUINAPRIL; VITAMIN B GROUP; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CALCULATION; CARDIOPULMONARY BYPASS; CASE REPORT; CONCENTRATION RESPONSE; CONVALESCENCE; DEFIBRILLATION; DEVICE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MONITORING; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MASSAGE; HEART TAMPONADE; HEMATOMA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MEDIASTINUM DISEASE; MEDICAL INSTRUMENTATION; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESUSCITATION; SEIZURE; SURGICAL TECHNIQUE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY;

EID: 0346656761     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659103pf689oa     Document Type: Article

References (11)

1. Lahita RG. Gender and age in lupus. In Lahita RG ed. Systemic lupus erythematosis, third edition. San Diego, CA: Academic Press, 1999: 129-43.
2. Lahita RG. The clinical presentation of systemic lupus erythematosis. In Lahita RG ed. Systemic lupus erythematosis, third edition. San Diego, CA: Academic Press, 1999: 325-36.
3. Morin AM, Boyer A-SJC, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosis requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996; 44: 313-16.
4. Bowie EJW, Thompson JH Jr, Pascuzzi CA, Owen CA Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-30.
5. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
6. Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemostasis Thromb 1982; 6: 263-85.
7. Ducart AR, Collard EL, Osselaer JC, Broka SM, Eucher PM, Joucken KL. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothoracic Vasc Anes 1997; 11: 878-79.
8. Shapiro S, Long M. Hematology: coagulation problems. In Lahita RG ed. Systemic lupus erythematosis, third edition. San Diego, CA: Academic Press, 1999: 871-85.
9. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972; 1: 75-95.
10. Bull BS, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. J Thorac Cardiovasc Surg 1975; 69: 685-89.
11. Koster A, Fischer T, Praus M et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 2002; 97: 837-41.